GPD1L: A Potential Drug Target and Biomarker (G23171)
GPD1L: A Potential Drug Target and Biomarker
Glycopharmacodic (GPD) proteins are a family of transmembrane proteins that play a crucial role in cell signaling and metabolism. GPD1L, a member of the GPD family, is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
GPD1L is a 12-kDa protein that is expressed in various tissues and cells, including brain, muscle, liver, and blood cells. It is involved in the intracellular signaling pathway known as the G-protein-coupled receptor (GPCR) signaling pathway, which is a widely established pathway for intracellular signaling that involves the interaction between GPCRs and G proteins. GPD1L is a GPCR that is composed of a catalytic 伪-heme protein and a transmembrane 尾-sheet protein.
The GPCR signaling pathway is a critical pathway that involves the regulation of various cellular processes, including cell survival, proliferation, migration, and signaling. GPD1L is involved in the regulation of several cellular processes, including cell adhesion, migration, and the regulation of ion channels.
GPD1L has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, GPD1L has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. GPD1L has also been shown to be involved in the regulation of cancer cell growth and survival, which may contribute to the development of cancer.
In addition to its involvement in disease, GPD1L has also been shown to be a potential drug target. The GPCR signaling pathway is a widely established pathway for the development of drug targets, and GPD1L is a potential drug target due to its involvement in several cellular processes that are involved in disease.
GPD1L has been shown to be involved in the regulation of cell adhesion, which is a critical process that is involved in the development of tissues and organs. GPD1L has been shown to be involved in the regulation of cell migration, which is a critical process that is involved in the development of tissues and organs and is also involved in the regulation of cancer cell migration.
In addition to its involvement in cell adhesion and migration, GPD1L has also been shown to be involved in the regulation of ion channels. Ion channels are critical for the regulation of various cellular processes, including muscle contractions and electrical signals. GPD1L has been shown to be involved in the regulation of ion channels, which may contribute to the regulation of various cellular processes.
GPD1L has also been shown to be involved in the regulation of cell survival and proliferation. Cell survival and proliferation are critical processes that are involved in the development and progression of diseases, including cancer. GPD1L has been shown to be involved in the regulation of cell survival and proliferation, which may contribute to the development and progression of these diseases.
GPD1L is also involved in the regulation of neurotransmitter release, which is a critical process that is involved in the regulation of various cellular processes, including mood, pain, and appetite. GPD1L has been shown to be involved in the regulation of neurotransmitter release, which may contribute to the regulation of various cellular processes.
In conclusion, GPD1L is a protein that has been shown to be involved in several cellular processes that are involved in disease, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target and biomarker makes GPD1L a promising target for future research in the field of drug development. Further studies are needed to fully understand the role of GPD1L in disease and to develop effective treatments.
Protein Name: Glycerol-3-phosphate Dehydrogenase 1 Like
Functions: Plays a role in regulating cardiac sodium current; decreased enzymatic activity with resulting increased levels of glycerol 3-phosphate activating the DPD1L-dependent SCN5A phosphorylation pathway, may ultimately lead to decreased sodium current; cardiac sodium current may also be reduced due to alterations of NAD(H) balance induced by DPD1L
The "GPD1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPD1L comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B
